Research on the Application Effect of Strengthening Risk Management in Continuous Renal Replacement Therapy Nursing of Critically Ill Patients

Abstract

Objective. To evaluate the efficacy of risk management in the nursing of critically ill patients on continuous renal replacement therapy (CRRT). Methods. In this retrospective study, 80 critically ill patients on continuous renal replacement therapy in our hospital from February 2020 to February 2021 were recruited. They were randomly assigned to receive either the risk management treatment (risk management group) or the conventional management treatment (conventional management group) via the random number table method. Outcome measurements included the occurrence of adverse events, complications, psychological status, quality of life, treatment compliance, duration of CRRT, and nursing satisfaction. Results. Risk management treatment was associated with lower incidence of adverse events compared to conventional management treatment ( $P$ value < 0.05). The risk management group also resulted in a lower incidence of complications compared to the conventional management group ( $P$ value < 0.05). Patients who received risk management treatments demonstrated a significantly lower anxiety/depression level and a higher World Health Organization Quality of Life Brief Version (WHOQOL-BREF) ( $P$ value < 0.05). The risk management group resulted in more cases with high compliance and fewer cases with moderate and poor compliance ( $P<0.05$ ). Risk management was associated with more cases with a CRRT duration less than 36 hours and 36–48 hours and fewer cases with a duration longer than 48 h (X2 = 2.999, $P$ value < 0.05). Patients who were given a risk management treatment had a higher nursing satisfaction compared to conventional management treatment (X2 = 4.501, $P$ value < 0.05). Conclusion. Risk management treatment in caring of critically ill patients on CRRT shows better efficacy than conventional management treatments.